156 related articles for article (PubMed ID: 38170086)
1. Acute Ischemic Stroke in an Infant With COVID-19 Infection and Delayed Diagnosis of Neurofibromatosis Type 1.
Akbar A; Creeden S
Cureus; 2024 Jan; 16(1):e51524. PubMed ID: 38170086
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis, stroke and basilar impression. Case report.
Piovesan EJ; Scola RH; Werneck LC; Zétola VH; Nóvak EM; Iwamoto FM; Piovesan LM
Arq Neuropsiquiatr; 1999 Jun; 57(2B):484-8. PubMed ID: 10450358
[TBL] [Abstract][Full Text] [Related]
3. Ischemic stroke with extensive vasculopathy in a patient with neurofibromatosis type 1.
Desmond FJ; Buture A; Kavanagh EC; Murphy S
Radiol Case Rep; 2022 Sep; 17(9):3370-3372. PubMed ID: 35865363
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of multiple café-au-lait macules for neurofibromatosis 1 in Chinese children.
Yao R; Wang L; Yu Y; Wang J; Shen Y
J Dermatol; 2016 May; 43(5):537-42. PubMed ID: 26458495
[TBL] [Abstract][Full Text] [Related]
5. Systemic hypertension followed by insidious stroke in a 12-year-old boy with childhood neurofibromatosis type 1 presenting with renal and cerebral artery vasculopathy.
Lee ML; Chang TM; Yang RC; Yang AD; Chen M
Turk J Pediatr; 2019; 61(4):629-634. PubMed ID: 31990487
[TBL] [Abstract][Full Text] [Related]
6. Early-onset stroke in two siblings with Neurofibromatosis type 1.
Rukavina K; Töpper R; Kunze A; Hess A; Glatzel M; Valdueza JM; Farschtschi S; Hagel C
Eur J Med Genet; 2019 Oct; 62(10):103710. PubMed ID: 31279841
[TBL] [Abstract][Full Text] [Related]
7. Case Report for Two Siblings Carrying Neurofibromatosis Type 1 with a Rare
Sayın Kocakap DB; Gündüz Ö; Özer L; Durak M
Balkan J Med Genet; 2021 Nov; 24(2):99-102. PubMed ID: 36249525
[TBL] [Abstract][Full Text] [Related]
8. [Anxiety disorders in type 1 neurofibromatosis: A case report].
Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
[TBL] [Abstract][Full Text] [Related]
9. Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder.
Stewart DR; Brems H; Gomes AG; Ruppert SL; Callens T; Williams J; Claes K; Bober MB; Hachen R; Kaban LB; Li H; Lin A; McDonald M; Melancon S; Ortenberg J; Radtke HB; Samson I; Saul RA; Shen J; Siqveland E; Toler TL; van Maarle M; Wallace M; Williams M; Legius E; Messiaen L
Genet Med; 2014 Jun; 16(6):448-59. PubMed ID: 24232412
[TBL] [Abstract][Full Text] [Related]
10. [Developmental manifestation in children with neurofibromatosis type 1].
Cohen R; Shuper A
Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
[TBL] [Abstract][Full Text] [Related]
11. Gene diagnosis of infantile neurofibromatosis type I: A case report.
Li MZ; Yuan L; Zhuo ZQ
World J Clin Cases; 2020 Nov; 8(22):5678-5683. PubMed ID: 33344560
[TBL] [Abstract][Full Text] [Related]
12. Cerebral Vasculopathy in Children with Neurofibromatosis Type 1.
Lehman LL; Ullrich NJ
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894478
[TBL] [Abstract][Full Text] [Related]
13. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
[TBL] [Abstract][Full Text] [Related]
14. A novel NF1 mutation in a pediatric patient with renal artery aneurysm.
Chillura I; Restivo GA; Callari S; Cibella S; D'Alessandro MM; Corrado C; Vallone M; Antona V; Corsello G
Ital J Pediatr; 2022 Nov; 48(1):186. PubMed ID: 36411470
[TBL] [Abstract][Full Text] [Related]
15. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
[TBL] [Abstract][Full Text] [Related]
16. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):454-64. PubMed ID: 26979265
[TBL] [Abstract][Full Text] [Related]
17. Spinal neurofibromatosis without café-au-lait macules in two families with null mutations of the NF1 gene.
Kaufmann D; Müller R; Bartelt B; Wolf M; Kunzi-Rapp K; Hanemann CO; Fahsold R; Hein C; Vogel W; Assum G
Am J Hum Genet; 2001 Dec; 69(6):1395-400. PubMed ID: 11704931
[TBL] [Abstract][Full Text] [Related]
18. A novel NF1 mutation in a Chinese patient with giant café-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality.
Tong HX; Li M; Zhang Y; Zhu J; Lu WQ
Genet Mol Res; 2012 Aug; 11(3):2972-8. PubMed ID: 22869071
[TBL] [Abstract][Full Text] [Related]
19. Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach.
Terry AR; Jordan JT; Schwamm L; Plotkin SR
Stroke; 2016 Jan; 47(1):60-5. PubMed ID: 26645253
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis type 1.
Boyd KP; Korf BR; Theos A
J Am Acad Dermatol; 2009 Jul; 61(1):1-14; quiz 15-6. PubMed ID: 19539839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
